Effectiveness of a Drug Reminder Mobile Phone Application in Adhering to Uric Acid Lowering Therapy in Patients with Gout: An Open-Label, Randomized Controlled Trial

Completed

• Conditions: Gout; Adherence; Mobile application; Uric acid

• Registration Number: TCTR20200123002
• Lead Sponsor: Siriraj hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-01-23
• Study Completion: 2022-03-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

1. Age 18 years with gout (defined by the ACR/EULAR criteria OR Rome criteria) who meet criteria for ULT
2. Serum UA > 6 mg/dL
3. Poor ULT adherence (defined as MTB-T questionnaire < 24)
4. Own an active smartphone that operates with iOS or Android operating systems
5. Have sufficient Thai language skills

Exclusion Criteria

1. Individuals with dementia
2. Individuals with psychiatric disorder
3. Individuals with visual, auditory or neurological disorder which interfere with smartphone use
4. Individuals who cannot complete the questionnaires

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
medical adherence 12 weeks pill count,Serum uric level 12 weeks Serum uric level

Secondary Outcome Measures

Name	Time	Method
Patient satisfaction to Drug diary app 12 weeks Satisfaction score